Patents by Inventor Claude Carelli

Claude Carelli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for treating osteoarthritis by administering linked variants of growth hormone and somatostatin
    Patent number: 10813980
    Abstract: Disclosed are advances relates to peptides including a sequence SEQ ID NO: 1 for use in the treatment of osteoarthritis.
    Type: Grant
    Filed: June 9, 2017
    Date of Patent: October 27, 2020
    Assignee: REGULAXIS
    Inventors: Claude Carelli, Christelle Vêtu, Raffaello Paolini
  • PEPTIDES FOR THE TREATMENT OF OSTEOARTHRITIS
    Publication number: 20190298808
    Abstract: Disclosed are advances relates to peptides including a sequence SEQ ID NO: 1 for use in the treatment of osteoarthritis.
    Type: Application
    Filed: June 9, 2017
    Publication date: October 3, 2019
    Inventors: Claude CARELLI, Christelle VÊTU, Raffaello PAOLINI
  • Methods for treating diseases with peptides that inhibit IGF-1
    Patent number: 9657080
    Abstract: The invention relates to peptides useful for inhibiting IGF-1 activity and their use as agents for inhibition of in vitro cell proliferation and for treatment of various diseases.
    Type: Grant
    Filed: January 30, 2015
    Date of Patent: May 23, 2017
    Assignee: Universite Pierre Et Marie Curie (Paris 6)
    Inventors: Claude Carelli, Zvi Laron, Gila Maor
  • METHODS FOR TREATING DISEASES WITH PEPTIDES THAT INHIBIT IGF-1
    Publication number: 20150133380
    Abstract: The invention relates to peptides useful for inhibiting IGF-1 activity and their use as agents for inhibition of in vitro cell proliferation and for treatment of various diseases.
    Type: Application
    Filed: January 30, 2015
    Publication date: May 14, 2015
    Inventors: Claude Carelli, Zvi Laron, Gila Maor
  • Method for inhibiting growth of chondrocytes in a subject by inhibiting IGF-1
    Patent number: 8975225
    Abstract: The invention relates to peptides useful for inhibiting IGF-1 activity and their use as agents for inhibition of in vitrocell proliferation and for treatment of various diseases.
    Type: Grant
    Filed: March 19, 2009
    Date of Patent: March 10, 2015
    Assignee: Universite Pierre et Marie Curie (Paris 6)
    Inventors: Claude Carelli, Zvi Laron, Gila Maor
  • Peptides and uses thereof to modulate IGF-1 synthesis and IGF-1 receptor expression
    Patent number: 8802815
    Abstract: The invention relates to peptides for modulate IGF-1 activity, a pharmaceutical composition comprising them as well as their applications as medicinal products and cell proliferation modulating agents in vitro.
    Type: Grant
    Filed: March 18, 2010
    Date of Patent: August 12, 2014
    Assignee: Universite Pierre et Marie Curie (Paris 6)
    Inventors: Claude Carelli, Zvi Laron, Gila Maor
  • PEPTIDES MODULATING THE ACTIVITY OF IGF-1 AND THE APPLICATIONS OF SAID PEPTIDES
    Publication number: 20120149640
    Abstract: The invention relates to peptides for modulate IGF-1 activity, a pharmaceutical composition comprising them as well as their applications as medicinal products and cell proliferation modulating agents in vitro.
    Type: Application
    Filed: March 18, 2010
    Publication date: June 14, 2012
    Inventors: Claude Carelli, Zvi Laron, Gila Maor
  • PEPTIDES FOR INHIBITING IGF-1
    Publication number: 20120135926
    Abstract: The invention relates to peptides useful for inhibiting IGF-1 activity and their use as agents for inhibition of in vitrocell proliferation and for treatment of various diseases.
    Type: Application
    Filed: March 19, 2009
    Publication date: May 31, 2012
    Applicant: UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6)
    Inventors: Claude Carelli, Zvi Laron, Gila Maor
  • Conjugates of haptenes and muramyl-peptides, endowed with immunogenic activity and compositions containing them
    Patent number: 4639512
    Abstract: The invention relates to an immunogenic principle containing a specific antigen determinant of a predetermined native antigen. This immunogenic principle is constituted by a conjugate between a hapten bearing said antigenic site and a muramyl-peptide, essentially in the absence of supporting macromolecules, this conjugate having an immunogenic effect not only against itself, but also with respect to the native antigen carrying said antigenic site.
    Type: Grant
    Filed: March 11, 1983
    Date of Patent: January 27, 1987
    Assignee: Agence Nationale de Valorisation de la Recherche
    Inventors: Francoise Audibert, Claude Carelli, Louis Chedid, Pierre LeFrancier, Michel Level, Jean Choay